Knight Therapeutics | GUD - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Acasti Pharma USD 1000 261.04M 2024-12
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.38M 172K 2026-03
Aurora Cannabis CAD 58.95M 2.24M 2026-03
Canopy Growth CAD 422.07M 53.78M 2026-03
Cronos Group USD 370.73M 5.53M 2026-06
Dianthus Therapeutics USD 54.58M 11.36M 2026-03
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
IQVIA Holdings USD 164.6M 2.3M 2026-06
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Moderna USD 391M 2M 2025-09
Omeros USD 611K 17K 2023-12
Organigram Holdings CAD 136.47M 1.34M 2026-03
Organon & Co USD 262.61M 40K 2026-06
Revvity USD 111.63M 174K 2026-06
Tectonic Therapeutic USD 18.83M 92.19K 2026-03
Tilray USD 116.52M 5.01M 2025-09
Viatris USD 1.16B 9.19M 2026-06
Xeris Pharmaceuticals USD 172.56M 6.34M 2026-03